tiprankstipranks
pc:thepa

The Pathfinder

Food & Beverage
The Pathfinder is a pioneering company in the non-alcoholic spirits industry, known for its innovative fermented and distilled elixirs. It launched its flagship product, Hemp and Root, in 2021, crafted from fermented hemp and an array of botanicals, offering a complex and aromatic zero-proof spirit. The company has expanded its offerings to include ready-to-drink formats like The Pathfinder Negroni and The Pathfinder Spritz, catering to the growing demand for sophisticated non-alcoholic beverages. With a strong presence in both retail and on-premise venues, The Pathfinder continues to redefine the zero-proof spirits category with its unique and bold products.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$4M
Total Amount Raised$4M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$4M
Latest Funding Amount$4M
Latest Funding RoundSeries B
Latest Funding RoundSeries B
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 10, 2025
Series B
$3.60M
―

Investors

Investor Name
Funding Round
Stoli Group
Series B

Related News and Analysis

The Partner Companies Secures $18.5 Million U.S. Defense Award to Scale Critical Germanium and Silicon Supply

The Partner Companies Secures $18.5 Million U.S. Defense Award to Scale Critical Germanium and Silicon Supply

New updates have been reported about The Partner Companies. The Partner Companies (TPC) is set to expand its...
3M ago
THEPA
The Partner Companies Secures $318M in Growth Capital as Lattice Materials Triples Infrared Manufacturing Capacity

The Partner Companies Secures $318M in Growth Capital as Lattice Materials Triples Infrared Manufacturing Capacity

New updates have been reported about The Partner Companies. The Partner Companies (TPC) is expanding its defense and...
3M ago
THEPA
Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

Talkiatry Partners With AMGA to Scale In-Network Psychiatric Access Nationwide

New updates have been reported about Talkiatry. Talkiatry has entered a strategic partnership with AMGA to expand in-network...
6m ago
TALKI
Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

Fibr AI Unveils Ads and LLM Personalization Tools to Lift Conversion and Cut Acquisition Costs

New updates have been reported about Fibr AI. Fibr AI has introduced two web personalization capabilities aimed at...
6m ago
FIBRA
TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

TransPerfect Expands Media Footprint With Acquisition of Italy’s Studio Emme

New updates have been reported about TransPerfect. TransPerfect has acquired Rome-based Studio Emme SpA, a long-established dubbing and...
7m ago
TRA2H
Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

Lettuce Financial to Acquire Carry, Adding $225 Million Retirement Platform for Solopreneurs

New updates have been reported about Lettuce Financial. Lettuce Financial plans to acquire Carry’s retirement and investing platform,...
7m ago
LETTU
BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

BQP Backs Quantum Hubs Legislation to Deepen Role in New York’s Growing Quantum Ecosystem

New updates have been reported about BQP. BQP is positioning itself at the center of New York’s quantum...
7m ago
BQPXX
Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

Cala Health Secures FDA Clearance for Next-Gen Wearable Tremor Device Cala kIQ Plus

New updates have been reported about Cala Health. Cala Health has received U.S. Food and Drug Administration clearance...
7m ago
CALAH
Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

Verismo to Unveil First-in-Human KIR-CAR Data for SynKIR-110 and SynKIR-310 at AACR 2026

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics will showcase pivotal first-in-human and preclinical data for...
18m ago
VER0L
Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

Verismo Therapeutics Secures $28 Million to Advance KIR-CAR Trials Ahead of Key 2026 Data Readout

New updates have been reported about Verismo Therapeutics. Verismo Therapeutics has obtained a $28 million capital infusion from...
18m ago
VER0L